Summary
In today’s Pharmalittle roundup, we’re reading about a Sarepta setback with its Duchenne drug, the FDA workload causing a delay, and more.
Source: STAT
Exclusive AI-Powered News Insights (For Members only)
Disclaimer:This content is AI-generated from various trusted sources and is intended for informational purposes only. While we strive for accuracy, we encourage you to verify details independently. Use the contact button to share feedback on any inaccuracies—your input helps us improve!
